Odyssey Acquisition S.A. lists on Euronext Amsterdam


  • Successfully raising €300 million
  • 11th SPAC listing on Euronext’s markets in 2021

Amsterdam – 2 July 2021 – Euronext today congratulates Odyssey Acquisition S.A., a newly formed Special Purpose Acquisition Company (SPAC) focusing on the European Healthcare and TMT (technology, media and telecom) sectors, on its listing on Euronext Amsterdam (ticker code: ODYSY). It is the 11th SPAC listing on Euronext markets year to date.

Odyssey Acquisition intends to focus on the European Healthcare and TMT sectors, two highly innovative industries that are experiencing robust growth and transformation and represent a significant investment opportunity for the European public capital markets. Leveraging its extensive network, the SPAC will focus on companies within such sectors which are in large and growing sub-segments, with differentiated business models, supported by strong structural tailwinds and solid ESG credentials, and which can benefit from access to the European public capital markets.

The newly listed SPAC is sponsored by a team of investors with experience in deal-making know-how, as well as specific industry expertise. At opening, the Unit price was set at €10.00 per share. Odyssey Acquisition S.A. has successfully raised €300 million in its Private Placement and Listing on Euronext Amsterdam.

Michael Zaoui, Chairman of Odyssey Acquisition, said: “We are delighted to have partnered with a team of highly experienced and talented executives in establishing Odyssey Acquisition. We look forward to playing an active role in supporting and accelerating the development of promising European businesses, including through enhanced access to public capital markets and using our combined network and expertise."


About Odyssey AcquisitionOdyssey Acquisition is a special purpose acquisition company incorporated under the laws of the Grand Duchy of Luxembourg as a public limited liability company for the purpose of completing a merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination with a business with principal operations in Europe, in the TMT or healthcare spaces. The company is sponsored by the Zaoui brothers together with Jean Raby, Olivier Brandicourt and Michel Combes.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €6.5 trillion in market capitalisation as of end June 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2023, Euronext N.V. - All rights reserved.